Plasminogen Activators in Tissues of the Immature and Estrogen-Stimulated Rat Uterus and in Uterine Luminal Fluid: Characterization and Properties*
- 1 March 1983
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 112 (3) , 890-897
- https://doi.org/10.1210/endo-112-3-890
Abstract
We have characterized the molecular properties of the plasminogen activators in different cell types comprising the immature and the estrogen-stimulated rat uterus and in rat uterine luminal fluid. There were two plasminogen activators in the immature (day 20) rat uterus with apparent molecular weights, determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, of 70,000 and 46,000. Both plasminogen activators were present in epithelial and in stromal plus myometrial cell fractions of the immature uterus, and after stimulation by 17β-estradiol, no new plasminogen activators were detected in either cell fraction. The Michaelis constants (Km) for the activation of dog plasminogen by extracts from epithelial cells and from stromal plus myometrial cells obtained from either immature or 17β-estradiol-stimulated uteri were similar (11 μM). The maximal velocity (Vmax), normalized to protein concentration, increased 2.5-fold in the stromal plus myometrial cell fraction and 6.5-fold in the epithelial cell fraction, upon hormone stimulation (2 μg 17β-estradiol/day·rat for 3 days). The greatest concentration of plasminogen activator activity was found in the luminal fluid from estrogen-stimulated uteri, where the Vmax per mg protein was more than 10-fold greater than that in the cell fractions from estrogen-stimulated uteri. The plasminogen activator activity of luminal fluid was inhibited by diisopropyl fluorophosphate and ρ-nitrophenyl ρ-guanidinobenzoate, was not inhibited by human α-1-proteinase inhibitor and human antithrombin III, and was inhibited by high, but not low, concentrations of soybean trypsin inhibitor and bovine pancreatic trypsin inhibitor. These studies indicate that the plasminogen activators in different cell types comprising the uterus are similar and show that the estrogen enhancement of uterine plasminogen activator activity is the result of an increase in Vmax. The presence, upon hormone stimulation, of an apparent concentration gradient of increasing plasminogen activator activity through the uterus from myometrium to epithelium to luminal fluid may be a reflection of the dynamic role of this protease in the physiology of the uterus.Keywords
This publication has 23 references indexed in Scilit:
- Purification of plasminogen activators from human seminal plasmaBiochemical Journal, 1978
- Direct fluorescent assay of urokinase and plasminogen activators of normal and malignant cells: kinetics and inhibitor profiles.Proceedings of the National Academy of Sciences, 1978
- Antipain and leupeptin restrict uterine DNA synthesis and function in mice.Proceedings of the National Academy of Sciences, 1977
- Plasminogen activator in early embryogenesis: Enzyme production by trophoblast and parietal endodermCell, 1976
- Studies on the role of plasminogen activator in ovulation. In vitro response of granulosa cells to gonadotropins, cyclic nucleotides, and prostaglandins.Journal of Biological Chemistry, 1976
- Estrogen-dependent trypsin-like activity in the rat uterusArchives of Biochemistry and Biophysics, 1976
- PEPTIDE CHAINS OF HUMAN PLASMIN - MECHANISM OF ACTIVATION OF HUMAN PLASMINOGEN TO PLASMIN1967
- Effect of Estradiol on Fibrinolytic Activity of Rat Uterus.Experimental Biology and Medicine, 1957
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951
- The Fluidity of Menstrual Blood, A Proteolytic Effect**This investigation was supported by a grant from the Committee for Research in Problems of Sex, the National Research Council.American Journal of Obstetrics and Gynecology, 1943